Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure
Perfusion · 2025
DOI: 10.1177/02676591241281792 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Perfusion, 2025. Verfasst von Tak Kyu Oh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Respiratory Distress Syndrome, Respiratory Insufficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Introduction
Extracorporeal membrane oxygenation (ECMO) is a vital intervention for acute respiratory distress syndrome (ARDS), yet its efficacy with coronavirus disease 2019 (COVID-19) remains unknown. This study compared the long-term mortality rates of patients receiving ECMO for COVID-19 with those experiencing other respiratory disease-associated ARDS.
Methods
This retrospective cohort study included adults with ARDS receiving ECMO for respiratory disease (COVID-19 and non-COVID-19) based on information collected from the National Health Insurance Service of South Korea from February 1, 2020, to December 31, 2021. The primary outcome was all-cause mortality at 6 months and 1 year post-ECMO initiation.
Results
Data from 3094 patients with COVID-19 ( N = 1095) and non-COVID-19 respiratory disease-associated ARDS ( N = 1999) who received ECMO support were analyzed. Despite a higher Charlson Comorbidity index in the non-COVID group, patients with COVID-19 had higher cumulative mortality rates at 6 months and 1 year post-ECMO initiation compared to those with non-COVID-19 respiratory diseases, after adjusting for confounders. Patients with COVID-19 also experienced longer intensive care unit stays, higher hospitalization costs, longer ECMO and mechanical ventilation durations, and lower intensity coverage.
Conclusions
Patients with COVID-19 requiring ECMO showed higher mortality rates, possibly due to its distinct long-lasting and potentially fatal consequences compared to other respiratory illnesses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
- Department of Anesthesiology and Pain Medicine, College of Medicine, Seoul National University, Seoul, South Korea.
ORCID-Profile: Tak Kyu Oh, In-Ae Song
Zitieren
APA
Oh, T. K., & Song, I. A. (2025). Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure. Perfusion. https://doi.org/10.1177/02676591241281792
Vancouver
Oh TK, Song IA. Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure. Perfusion. 2025. doi:10.1177/02676591241281792
BibTeX
@article{Oh2025,
author = {Oh, Tak Kyu and Song, In-Ae},
title = {Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure},
journal = {Perfusion},
year = {2025},
doi = {10.1177/02676591241281792}
}
EUVIMED